This trial is testing a new cancer-detecting tracer to see if it's more accurate than current imaging methods.
1 Primary · 0 Secondary · Reporting Duration: 1 year
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: PET/MRI · No Placebo Group · Phase 1
Age 18+ · Male Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: